Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension

Study:

A Phase 4, Randomized-withdrawal, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Clinical Benefit of Midodrine Hydrochloride in Male and Female Subjects With Symptomatic Orthostatic Hypotension

Rationale:

n/a

Purpose:

To study the effect of midodrine against the symptoms of orthostatic hypotension

Study Status: Active, not recruiting

Recruiting:
n/a

Condition Intervention Phase
Symptomatic Orthostatic Hypotension Drug: Midodrine HCl
Drug: Placebo
Phase 4

Verified by Shire Development LLC December, 2013

Sponsored by: Shire Development LLC
Information provided by: Shire Development LLC
ClinicalTrials.gov identifier: NCT01515865

Study Type: Interventional

Study Design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Cleveland Clinic
Cleveland, Ohio 44195
United States

n/a

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site